BRCA1 and breast carcinoma: Further supporting this idea is the finding that genetic variations in HMMR27 modify breast cancer risk in BRCA1 mutation carriers and DYNLL1 expression correlates with survival in BRCA1-mutant patients that develop ovarian cancer28.